Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Adapalene/BP Gel in Acne Vulgaris
NCT02709902Phase 1Completed
- Start
- Sep 2015
- Primary completion
- Feb 2016
- Modality
- Hydrogel Systems, Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of adapalene + benzoyl peroxide in acne vulgaris (3 arms). Primary endpoints: Change in inflammatory lesion counts at 12 weeks and Change in non-inflammatory lesion counts at 12 weeks. Started Sep 2015; status: completed.
02
Drugs
adapalene + benzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02709902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02709902.